{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T00:39:21Z","timestamp":1793407161430,"version":"4.5.0"},"reference-count":112,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI16-00784"],"award-info":[{"award-number":["PI16-00784"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["P16-01334"],"award-info":[{"award-number":["P16-01334"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","award":["IPT1\/0019 ISCIIIS-GEFI\/ERDF"],"award-info":[{"award-number":["IPT1\/0019 ISCIIIS-GEFI\/ERDF"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010566","name":"Consejer\u00eda de Salud, Junta de Andaluc\u00eda","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010566","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Proteomics"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1016\/j.jprot.2020.103757","type":"journal-article","created":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T11:09:40Z","timestamp":1585739380000},"page":"103757","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Molecular signatures of atherosclerotic plaques: An up-dated panel of protein related markers"],"prefix":"10.1016","volume":"221","author":[{"given":"S.","family":"Eslava-Alcon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.J.","family":"Extremera-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Gonz\u00e1lez-Rovira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Rosal-Vela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Rojas-Torres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Beltran-Camacho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Sanchez-Gomar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Jim\u00e9nez-Palomares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.A.","family":"Alonso-Pi\u00f1ero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Conejero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Doiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Olarte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Foncubierta-Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Lozano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.J.","family":"Garc\u00eda-Cozar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Rodr\u00edguez-Pi\u00f1ero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Alvarez-Llamas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.C.","family":"Duran-Ruiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.jprot.2020.103757_bb0005","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/s11936-010-0074-9","article-title":"Pathology and vulnerability of atherosclerotic plaque: identification, treatment options, and individual patient differences for prevention of stroke","volume":"12","author":"Yazdani","year":"2010","journal-title":"Curr. Treat Options Cardiovasc. Med."},{"issue":"11","key":"10.1016\/j.jprot.2020.103757_bb0010","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1038\/nm1102-1257","article-title":"Stabilization of atherosclerotic plaques: new mechanisms and clinical targets","volume":"8","author":"Libby","year":"2002","journal-title":"Nat. Med."},{"issue":"1\u20132","key":"10.1016\/j.jprot.2020.103757_bb0015","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.ejphar.2007.01.077","article-title":"Atorvastatin modulates the profile of proteins released by human atherosclerotic plaques","volume":"562","author":"Duran","year":"2007","journal-title":"Eur. J. Pharmacol."},{"issue":"7\u20138","key":"10.1016\/j.jprot.2020.103757_bb0020","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1002\/prca.201200119","article-title":"Proteomics of plaques and novel sources of potential biomarkers for atherosclerosis","volume":"7","author":"Bleijerveld","year":"2013","journal-title":"Proteomics Clin. Appl."},{"issue":"6","key":"10.1016\/j.jprot.2020.103757_bb0025","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1002\/pmic.200300389","article-title":"Proteomic analysis of human vessels: application to atherosclerotic plaques","volume":"3","author":"Duran","year":"2003","journal-title":"Proteomics"},{"issue":"6","key":"10.1016\/j.jprot.2020.103757_bb0030","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/S1474-4422(19)30035-3","article-title":"Imaging biomarkers of vulnerable carotid plaques for stroke risk prediction and their potential clinical implications","volume":"18","author":"Saba","year":"2019","journal-title":"Lancet Neurol."},{"issue":"1","key":"10.1016\/j.jprot.2020.103757_bb0035","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.atherosclerosis.2008.07.001","article-title":"A proteomic approach to differentiate histologically classified stable and unstable plaques from human carotid arteries","volume":"203","author":"Lepedda","year":"2009","journal-title":"Atherosclerosis"},{"issue":"2","key":"10.1016\/j.jprot.2020.103757_bb0040","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.atherosclerosis.2013.12.019","article-title":"Local carotid atherosclerotic plaque proteins for the identification of circulating biomarkers in coronary patients","volume":"233","author":"Malaud","year":"2014","journal-title":"Atherosclerosis"},{"issue":"5","key":"10.1016\/j.jprot.2020.103757_bb0045","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1161\/01.CIR.92.5.1355","article-title":"A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association","volume":"92","author":"Stary","year":"1995","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.jprot.2020.103757_bb0050","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1136\/heart.83.3.361","article-title":"The pathophysiology of acute coronary syndromes","volume":"83","author":"Davies","year":"2000","journal-title":"Heart"},{"issue":"12","key":"10.1016\/j.jprot.2020.103757_bb0055","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.1016\/j.jacc.2005.03.034","article-title":"Picking plaques that pop","volume":"45","author":"Narula","year":"2005","journal-title":"J. Am. Coll. Cardiol."},{"issue":"1","key":"10.1016\/j.jprot.2020.103757_bb0060","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1080\/10408363.2016.1241214","article-title":"Deciphering acute coronary syndrome biomarkers: high-resolution proteomics in platelets, thrombi and microparticles","volume":"54","author":"Navas-Carrillo","year":"2017","journal-title":"Crit. Rev. Clin. Lab. Sci."},{"issue":"5","key":"10.1016\/j.jprot.2020.103757_bb0065","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1586\/14789450.5.5.679","article-title":"Recent advances in atherosclerosis-based proteomics: new biomarkers and a future perspective","volume":"5","author":"Alvarez-Llamas","year":"2008","journal-title":"Expert Rev. Proteomics"},{"key":"10.1016\/j.jprot.2020.103757_bb0070","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s12014-017-9157-x","article-title":"A novel workflow combining plaque imaging, plaque and plasma proteomics identifies biomarkers of human coronary atherosclerotic plaque disruption","volume":"14","author":"Lee","year":"2017","journal-title":"Clin. Proteomics"},{"issue":"1","key":"10.1016\/j.jprot.2020.103757_bb0075","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1002\/path.1749","article-title":"Proteomic analysis of differential protein expression in human atherosclerotic plaque progression","volume":"206","author":"Donners","year":"2005","journal-title":"J. Pathol."},{"issue":"3","key":"10.1016\/j.jprot.2020.103757_bb0080","first-page":"106","article-title":"The use of biomarkers for the early detection of vulnerable atherosclerotic plaques and vulnerable patients. A review","volume":"2","author":"Benedek","year":"2016","journal-title":"J. Cardiovasc. Emerg."},{"issue":"9","key":"10.1016\/j.jprot.2020.103757_bb0085","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1002\/prca.200700190","article-title":"Vascular proteomics","volume":"1","author":"Vivanco","year":"2007","journal-title":"Proteomics Clin. Appl."},{"issue":"1","key":"10.1016\/j.jprot.2020.103757_bb0090","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.atherosclerosis.2015.07.001","article-title":"Modelling atherosclerosis by proteomics: molecular changes in the ascending aortas of cholesterol-fed rabbits","volume":"242","author":"Xu","year":"2015","journal-title":"Atherosclerosis"},{"issue":"4","key":"10.1016\/j.jprot.2020.103757_bb0095","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.bbadis.2015.12.006","article-title":"Cytoskeleton deregulation and impairment in amino acids and energy metabolism in early atherosclerosis at aortic tissue with reflection in plasma","volume":"1862","author":"Martin-Lorenzo","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.jprot.2020.103757_bb0100","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.jprot.2015.06.005","article-title":"Molecular anatomy of ascending aorta in atherosclerosis by MS imaging: specific lipid and protein patterns reflect pathology","volume":"126","author":"Martin-Lorenzo","year":"2015","journal-title":"J. Proteome"},{"key":"10.1016\/j.jprot.2020.103757_bb0105","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.jprot.2013.01.032","article-title":"Deregulation of smooth muscle cell cytoskeleton within the human atherosclerotic coronary media layer","volume":"82","author":"de la Cuesta","year":"2013","journal-title":"J. Proteome"},{"issue":"4","key":"10.1016\/j.jprot.2020.103757_bb0110","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1172\/JCI86924","article-title":"Extracellular matrix proteomics identifies molecular signature of symptomatic carotid plaques","volume":"127","author":"Langley","year":"2017","journal-title":"J. Clin. Invest."},{"issue":"4","key":"10.1016\/j.jprot.2020.103757_bb0115","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.bbrc.2010.09.103","article-title":"Consistent differences in protein distribution along the longitudinal axis in symptomatic carotid atherosclerotic plaques","volume":"401","author":"Olson","year":"2010","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jprot.2020.103757_bb0120","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.yjmcc.2017.02.001","article-title":"The atheroma plaque secretome stimulates the mobilization of endothelial progenitor cells ex vivo","volume":"105","author":"Vega","year":"2017","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"8","key":"10.1016\/j.jprot.2020.103757_bb0125","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1161\/ATVBAHA.115.305365","article-title":"Circulating FABP4 is a prognostic biomarker in patients with acute coronary syndrome but not in asymptomatic individuals","volume":"35","author":"Reiser","year":"2015","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"10","key":"10.1016\/j.jprot.2020.103757_bb0130","doi-asserted-by":"crossref","first-page":"2960","DOI":"10.1016\/j.jprot.2011.12.005","article-title":"Secretome analysis of atherosclerotic and non-atherosclerotic arteries reveals dynamic extracellular remodeling during pathogenesis","volume":"75","author":"de la Cuesta","year":"2012","journal-title":"J. Proteome"},{"key":"10.1016\/j.jprot.2020.103757_bb0135","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1186\/1479-5876-11-260","article-title":"Secreted proteins from carotid endarterectomy: an untargeted approach to disclose molecular clues of plaque progression","volume":"11","author":"Rocchiccioli","year":"2013","journal-title":"J. Transl. Med."},{"issue":"3","key":"10.1016\/j.jprot.2020.103757_bb0140","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1021\/acs.jproteome.5b00936","article-title":"Proteomic profile of unstable atheroma plaque: increased neutrophil Defensin 1, Clusterin, and apolipoprotein E levels in carotid secretome","volume":"15","author":"Aragones","year":"2016","journal-title":"J. Proteome Res."},{"issue":"1","key":"10.1016\/j.jprot.2020.103757_bb0145","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1186\/s12872-016-0320-5","article-title":"Adipo\/cytokines in atherosclerotic secretomes: increased visfatin levels in unstable carotid plaque","volume":"16","author":"Auguet","year":"2016","journal-title":"BMC Cardiovasc. Disord."},{"issue":"15","key":"10.1016\/j.jprot.2020.103757_bb0150","doi-asserted-by":"crossref","first-page":"2216","DOI":"10.1161\/01.CIR.0000136814.87170.B1","article-title":"Identification by a differential proteomic approach of heat shock protein 27 as a potential marker of atherosclerosis","volume":"110","author":"Martin-Ventura","year":"2004","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.jprot.2020.103757_bb0155","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1056\/NEJM199902113400607","article-title":"Acute-phase proteins and other systemic responses to inflammation","volume":"340","author":"Gabay","year":"1999","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.jprot.2020.103757_bb0160","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1053\/ejvs.2001.1321","article-title":"Increased acute phase reactants are associated with levels of lipoproteins and increased carotid plaque volume","volume":"21","author":"Gronholdt","year":"2001","journal-title":"Eur. J. Vasc. Endovasc. Surg."},{"key":"10.1016\/j.jprot.2020.103757_bb0165","first-page":"953461","article-title":"Acute phase reactants as novel predictors of cardiovascular disease","volume":"2012","author":"Ahmed","year":"2012","journal-title":"ISRN Inflamm."},{"issue":"11","key":"10.1016\/j.jprot.2020.103757_bb0170","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0113460","article-title":"Higher fibrinogen level is independently linked with the presence and severity of new-onset coronary atherosclerosis among Han Chinese population","volume":"9","author":"Zhang","year":"2014","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.jprot.2020.103757_bb0175","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.hlc.2018.06.1057","article-title":"Markers of atherosclerosis: part 1 - serological markers","volume":"28","author":"Tibaut","year":"2019","journal-title":"Heart Lung Circ."},{"issue":"3","key":"10.1016\/j.jprot.2020.103757_bb0180","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1111\/j.1538-7836.2009.03727.x","article-title":"Longitudinal assessment of fibrinogen in relation to subclinical cardiovascular disease: the CARDIA study","volume":"8","author":"Green","year":"2010","journal-title":"J. Thromb. Haemost."},{"issue":"7","key":"10.1016\/j.jprot.2020.103757_bb0185","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1161\/01.STR.0000169931.96670.fc","article-title":"Prognostic impact of fibrinogen in carotid atherosclerosis: nonspecific indicator of inflammation or independent predictor of disease progression?","volume":"36","author":"Sabeti","year":"2005","journal-title":"Stroke"},{"issue":"6","key":"10.1016\/j.jprot.2020.103757_bb0190","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.amjcard.2012.11.060","article-title":"Relation of fibrinogen level with cardiovascular events in patients with coronary artery disease","volume":"111","author":"Ndrepepa","year":"2013","journal-title":"Am. J. Cardiol."},{"issue":"4","key":"10.1016\/j.jprot.2020.103757_bb0195","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.jacc.2013.03.072","article-title":"Aggregate risk score based on markers of inflammation, cell stress, and coagulation is an independent predictor of adverse cardiovascular outcomes","volume":"62","author":"Eapen","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"issue":"3","key":"10.1016\/j.jprot.2020.103757_bb0200","first-page":"1","article-title":"Biomarkers of atherosclerosis: is the evaluation essential preoperatively?","volume":"2","author":"Choudhury","year":"2017","journal-title":"Atherosclerosis: Open Access"},{"issue":"4","key":"10.1016\/j.jprot.2020.103757_bb0205","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0094264","article-title":"Acute coronary syndrome remodels the protein cargo and functions of high-density lipoprotein subfractions","volume":"9","author":"Tan","year":"2014","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.jprot.2020.103757_bb0210","doi-asserted-by":"crossref","first-page":"3214","DOI":"10.7150\/thno.22704","article-title":"Serum amyloid P component therapeutically attenuates atherosclerosis in mice via its effects on macrophages","volume":"8","author":"Xi","year":"2018","journal-title":"Theranostics"},{"issue":"3","key":"10.1016\/j.jprot.2020.103757_bb0215","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1161\/ATVBAHA.109.194944","article-title":"Local atherosclerotic plaques are a source of prognostic biomarkers for adverse cardiovascular events","volume":"30","author":"de Kleijn","year":"2010","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"4","key":"10.1016\/j.jprot.2020.103757_bb0220","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1161\/ATVBAHA.118.311577","article-title":"Osteopontin in vascular disease","volume":"39","author":"Lok","year":"2019","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"8","key":"10.1016\/j.jprot.2020.103757_bb0225","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1084\/jem.20020911","article-title":"Inactivation of the osteopontin gene enhances vascular calcification of matrix Gla protein-deficient mice: evidence for osteopontin as an inducible inhibitor of vascular calcification in vivo","volume":"196","author":"Speer","year":"2002","journal-title":"J. Exp. Med."},{"issue":"4","key":"10.1016\/j.jprot.2020.103757_bb0230","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.molmet.2014.03.004","article-title":"Osteopontin: a novel regulator at the cross roads of inflammation, obesity and diabetes","volume":"3","author":"Kahles","year":"2014","journal-title":"Mol. Metab."},{"issue":"7","key":"10.1016\/j.jprot.2020.103757_bb0235","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1161\/01.ATV.0000133194.94939.42","article-title":"Vascular calcification: mechanisms and clinical ramifications","volume":"24","author":"Abedin","year":"2004","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"5","key":"10.1016\/j.jprot.2020.103757_bb0240","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1161\/01.CIR.0000055739.13639.D7","article-title":"Osteopontin transgenic mice fed a high-cholesterol diet develop early fatty-streak lesions","volume":"107","author":"Isoda","year":"2003","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.jprot.2020.103757_bb0245","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.atherosclerosis.2009.12.024","article-title":"Associations between plasma osteopontin levels and the severities of coronary and aortic atherosclerosis","volume":"210","author":"Momiyama","year":"2010","journal-title":"Atherosclerosis"},{"issue":"1","key":"10.1016\/j.jprot.2020.103757_bb0250","doi-asserted-by":"crossref","first-page":"22","DOI":"10.2174\/157340311795677680","article-title":"Atherosclerotic plaque biomarkers: beyond the horizon of the vulnerable plaque","volume":"7","author":"Van Lammeren Guss","year":"2011","journal-title":"Curr. Cardiol. Rev."},{"key":"10.1016\/j.jprot.2020.103757_bb0255","series-title":"The Role of Lipids and Lipoproteins in Atherosclerosis","author":"Linton","year":"2000"},{"issue":"5","key":"10.1016\/j.jprot.2020.103757_bb0260","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1093\/qjmed\/hcl027","article-title":"Apolipoproteins as markers and managers of coronary risk","volume":"99","author":"Chan","year":"2006","journal-title":"QJM"},{"issue":"6","key":"10.1016\/j.jprot.2020.103757_bb0265","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1055\/s-0037-1614155","article-title":"Short-term prognostic value of lipid measurements in patients with angina pectoris. The ECAT Angina Pectoris Study Group: European Concerted Action on Thrombosis and Disabilities","volume":"84","author":"Bolibar","year":"2000","journal-title":"Thromb. Haemost."},{"issue":"13","key":"10.1016\/j.jprot.2020.103757_bb0270","first-page":"1188","article-title":"Apolipoproteins are new and better risk indicators of myocardial infarction","volume":"101","author":"Walldius","year":"2004","journal-title":"Lakartidningen"},{"issue":"3","key":"10.1016\/j.jprot.2020.103757_bb0275","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1161\/CIRCOUTCOMES.110.959247","article-title":"A meta-analysis of low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, and apolipoprotein B as markers of cardiovascular risk","volume":"4","author":"Sniderman","year":"2011","journal-title":"Circ. Cardiovasc. Qual. Outcomes"},{"issue":"6","key":"10.1016\/j.jprot.2020.103757_bb0280","first-page":"140","article-title":"ApoB\/Apo A-I ratio and cardiovascular risk prediction","volume":"88","author":"Moreira Lima","year":"2007","journal-title":"Arq. Bras. Cardiol."},{"issue":"1","key":"10.1016\/j.jprot.2020.103757_bb0285","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1161\/ATVBAHA.110.213892","article-title":"Macrophage, but not systemic, apolipoprotein E is necessary for macrophage reverse cholesterol transport in vivo","volume":"31","author":"Zanotti","year":"2011","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"5081","key":"10.1016\/j.jprot.2020.103757_bb0290","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1126\/science.1411543","article-title":"Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E","volume":"258","author":"Zhang","year":"1992","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.jprot.2020.103757_bb0295","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/0092-8674(92)90362-G","article-title":"Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells","volume":"71","author":"Plump","year":"1992","journal-title":"Cell"},{"issue":"10","key":"10.1016\/j.jprot.2020.103757_bb0300","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1194\/jlr.M200108-JLR200","article-title":"Physiological expression of macrophage apoE in the artery wall reduces atherosclerosis in severely hyperlipidemic mice","volume":"43","author":"Fazio","year":"2002","journal-title":"J. Lipid Res."},{"issue":"39","key":"10.1016\/j.jprot.2020.103757_bb0305","doi-asserted-by":"crossref","first-page":"36742","DOI":"10.1074\/jbc.M106027200","article-title":"Retrovirus-mediated expression of apolipoprotein A-I in the macrophage protects against atherosclerosis in vivo","volume":"276","author":"Ishiguro","year":"2001","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.jprot.2020.103757_bb0310","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1161\/01.ATV.0000148323.94021.e5","article-title":"ACAT1 deficiency disrupts cholesterol efflux and alters cellular morphology in macrophages","volume":"25","author":"Dove","year":"2005","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.jprot.2020.103757_bb0315","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.cca.2013.06.006","article-title":"Foam cells in atherosclerosis","volume":"424","author":"Yu","year":"2013","journal-title":"Clin. Chim. Acta"},{"issue":"12","key":"10.1016\/j.jprot.2020.103757_bb0320","doi-asserted-by":"crossref","first-page":"6232","DOI":"10.1074\/jbc.M116.713818","article-title":"Myeloid acyl-CoA:cholesterol acyltransferase 1 deficiency reduces lesion macrophage content and suppresses atherosclerosis progression","volume":"291","author":"Huang","year":"2016","journal-title":"J. Biol. Chem."},{"issue":"21","key":"10.1016\/j.jprot.2020.103757_bb0325","doi-asserted-by":"crossref","first-page":"2604","DOI":"10.1161\/01.CIR.103.21.2604","article-title":"Acyl-CoA:cholesterol acyltransferase inhibition reduces atherosclerosis in apolipoprotein E-deficient mice","volume":"103","author":"Kusunoki","year":"2001","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.jprot.2020.103757_bb0330","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1194\/jlr.S091793","article-title":"Adipokine FABP4 integrates energy stores and counterregulatory metabolic responses","volume":"60","author":"Prentice","year":"2019","journal-title":"J. Lipid Res."},{"issue":"1","key":"10.1016\/j.jprot.2020.103757_bb0335","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.atherosclerosis.2012.09.037","article-title":"Increased expression of fatty acid binding protein 4 and leptin in resident macrophages characterises atherosclerotic plaque rupture","volume":"226","author":"Lee","year":"2013","journal-title":"Atherosclerosis"},{"issue":"14","key":"10.1016\/j.jprot.2020.103757_bb0340","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1093\/eurheartj\/ehq387","article-title":"Adipocyte fatty acid binding protein in atherosclerotic plaques is associated with local vulnerability and is predictive for the occurrence of adverse cardiovascular events","volume":"32","author":"Peeters","year":"2011","journal-title":"Eur. Heart J."},{"issue":"6","key":"10.1016\/j.jprot.2020.103757_bb0345","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/nrd2589","article-title":"Fatty acid-binding proteins: role in metabolic diseases and potential as drug targets","volume":"7","author":"Furuhashi","year":"2008","journal-title":"Nat. Rev. Drug Discov."},{"issue":"12","key":"10.1016\/j.jprot.2020.103757_bb0350","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0028785","article-title":"Fatty acid binding protein 4 is associated with carotid atherosclerosis and outcome in patients with acute ischemic stroke","volume":"6","author":"Holm","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.jprot.2020.103757_bb0355","first-page":"502813","article-title":"Heat shock proteins: pathogenic role in atherosclerosis and potential therapeutic implications","volume":"2012","author":"Kilic","year":"2012","journal-title":"Autoimmune Dis."},{"issue":"9","key":"10.1016\/j.jprot.2020.103757_bb0360","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1161\/CIRCULATIONAHA.105.541219","article-title":"Expression of heat shock protein 27 in human atherosclerotic plaques and increased plasma level of heat shock protein 27 in patients with acute coronary syndrome","volume":"114","author":"Park","year":"2006","journal-title":"Circulation"},{"issue":"16","key":"10.1016\/j.jprot.2020.103757_bb0365","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1016\/j.jacc.2013.05.041","article-title":"Serum heat shock protein 27 levels represent a potential therapeutic target for atherosclerosis: observations from a human cohort and treatment of female mice","volume":"62","author":"Seibert","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"issue":"1","key":"10.1016\/j.jprot.2020.103757_bb0370","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1556\/2060.105.2018.1.4","article-title":"Heat shock proteins and cardiovascular disease","volume":"105","author":"Rodriguez-Iturbe","year":"2018","journal-title":"Physiol. Int."},{"key":"10.1016\/j.jprot.2020.103757_bb0375","first-page":"141","article-title":"Characterization of the human atheroma plaque secretome by proteomic analysis","volume":"357","author":"Duran","year":"2007","journal-title":"Methods Mol. Biol."},{"issue":"12","key":"10.1016\/j.jprot.2020.103757_bb0380","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1161\/hq1201.100263","article-title":"Temporal expression of heat shock proteins 60 and 70 at lesion-prone sites during atherogenesis in ApoE-deficient mice","volume":"21","author":"Kanwar","year":"2001","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"1","key":"10.1016\/j.jprot.2020.103757_bb0385","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.atherosclerosis.2009.04.026","article-title":"Heat-shock protein 90: a novel autoantigen in human carotid atherosclerosis","volume":"207","author":"Businaro","year":"2009","journal-title":"Atherosclerosis"},{"issue":"2","key":"10.1016\/j.jprot.2020.103757_bb0390","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1093\/cvr\/cvq046","article-title":"Heat shock protein 90 inhibitors attenuate inflammatory responses in atherosclerosis","volume":"86","author":"Madrigal-Matute","year":"2010","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.jprot.2020.103757_bb0395","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.3389\/fimmu.2017.01908","article-title":"S100 proteins as an important regulator of macrophage inflammation","volume":"8","author":"Xia","year":"2017","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.jprot.2020.103757_bb0400","first-page":"92","article-title":"S100\/calgranulins EN-RAGEing the blood vessels: implications for inflammatory responses and atherosclerosis","volume":"1","author":"Hofmann Bowman","year":"2011","journal-title":"Am. J. Cardiovasc. Dis."},{"issue":"2","key":"10.1016\/j.jprot.2020.103757_bb0405","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1161\/ATVBAHA.111.236927","article-title":"S100A8 and S100A9 in cardiovascular biology and disease","volume":"32","author":"Averill","year":"2012","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.jprot.2020.103757_bb0410","doi-asserted-by":"crossref","first-page":"4980251","DOI":"10.1155\/2016\/4980251","article-title":"The correlation of serum myeloid-related Protein-8\/14 and eosinophil cationic protein in patients with coronary artery disease","volume":"2016","author":"Xia","year":"2016","journal-title":"Biomed. Res. Int."},{"issue":"12","key":"10.1016\/j.jprot.2020.103757_bb0415","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.1161\/ATVBAHA.115.302072","article-title":"S100A12 and the S100\/Calgranulins: emerging biomarkers for atherosclerosis and possibly therapeutic targets","volume":"35","author":"Oesterle","year":"2015","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"11","key":"10.1016\/j.jprot.2020.103757_bb0420","doi-asserted-by":"crossref","first-page":"3172","DOI":"10.1182\/blood-2011-05-353482","article-title":"Regulation of fibrinolysis by S100A10 in vivo","volume":"118","author":"Surette","year":"2011","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.jprot.2020.103757_bb0425","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.tcm.2004.04.001","article-title":"The functions of plasminogen in cardiovascular disease","volume":"14","author":"Plow","year":"2004","journal-title":"Trends Cardiovasc. Med."},{"issue":"3","key":"10.1016\/j.jprot.2020.103757_bb0430","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1111\/j.1538-7836.2005.01765.x","article-title":"Plasminogen activation: a mediator of vascular smooth muscle cell apoptosis in atherosclerotic plaques","volume":"4","author":"Rossignol","year":"2006","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.jprot.2020.103757_bb0435","doi-asserted-by":"crossref","first-page":"406273","DOI":"10.1155\/2012\/406273","article-title":"The annexin A2\/S100A10 system in health and disease: emerging paradigms","volume":"2012","author":"Hedhli","year":"2012","journal-title":"J. Biomed. Biotechnol."},{"issue":"5","key":"10.1016\/j.jprot.2020.103757_bb0440","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1186\/1479-7364-1-5-355","article-title":"Expression profiling of cardiovascular disease","volume":"1","author":"Archacki","year":"2004","journal-title":"Hum Genomics"},{"issue":"4","key":"10.1016\/j.jprot.2020.103757_bb0445","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1159\/000065546","article-title":"Characterization of differential gene expression in quiescent and invasive human arterial smooth muscle cells","volume":"39","author":"Blindt","year":"2002","journal-title":"J. Vasc. Res."},{"key":"10.1016\/j.jprot.2020.103757_bb0450","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.jprot.2014.07.016","article-title":"Proteomic characterization of human coronary thrombus in patients with ST-segment elevation acute myocardial infarction","volume":"109","author":"Alonso-Orgaz","year":"2014","journal-title":"J. Proteome"},{"key":"10.1016\/j.jprot.2020.103757_bb0455","doi-asserted-by":"crossref","first-page":"36","DOI":"10.20517\/2574-1209.2018.51","article-title":"Vascular smooth muscle cell contractile function and mechanotransduction","volume":"2","author":"Ahmed","year":"2018","journal-title":"Vessel Plus"},{"key":"10.1016\/j.jprot.2020.103757_bb0460","article-title":"The role of vascular smooth muscle cells in the physiology and pathophysiology of blood vessels, muscle cell and tissue","volume":"229","author":"Bacakova","year":"2018","journal-title":"Intechopen"},{"issue":"4","key":"10.1016\/j.jprot.2020.103757_bb0465","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1093\/cvr\/cvy022","article-title":"Smooth muscle cell fate and plasticity in atherosclerosis","volume":"114","author":"Allahverdian","year":"2018","journal-title":"Cardiovasc. Res."},{"issue":"4","key":"10.1016\/j.jprot.2020.103757_bb0470","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1093\/cvr\/cvy010","article-title":"Role of smooth muscle cells in vascular calcification: implications in atherosclerosis and arterial stiffness","volume":"114","author":"Durham","year":"2018","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.jprot.2020.103757_bb0475","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.atherosclerosis.2016.10.031","article-title":"Talin and vinculin are downregulated in atherosclerotic plaque; Tampere vascular study","volume":"255","author":"von Essen","year":"2016","journal-title":"Atherosclerosis"},{"issue":"1","key":"10.1016\/j.jprot.2020.103757_bb0480","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.gene.2016.02.040","article-title":"Calponin isoforms CNN1, CNN2 and CNN3: regulators for actin cytoskeleton functions in smooth muscle and non-muscle cells","volume":"585","author":"Liu","year":"2016","journal-title":"Gene"},{"key":"10.1016\/j.jprot.2020.103757_bb0485","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.yjmcc.2014.04.003","article-title":"Transcriptome profiling reveals that the SM22alpha-regulated molecular pathways contribute to vascular pathology","volume":"72","author":"Chen","year":"2014","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"10","key":"10.1016\/j.jprot.2020.103757_bb0490","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1161\/01.RES.0000147961.09840.fb","article-title":"A G\/C element mediates repression of the SM22alpha promoter within phenotypically modulated smooth muscle cells in experimental atherosclerosis","volume":"95","author":"Wamhoff","year":"2004","journal-title":"Circ. Res."},{"issue":"7","key":"10.1016\/j.jprot.2020.103757_bb0495","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1161\/01.RES.0000126417.38728.F6","article-title":"SM22alpha modulates vascular smooth muscle cell phenotype during atherogenesis","volume":"94","author":"Feil","year":"2004","journal-title":"Circ. Res."},{"issue":"8","key":"10.1016\/j.jprot.2020.103757_bb0500","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1161\/CIRCRESAHA.109.213900","article-title":"Disruption of SM22 promotes inflammation after artery injury via nuclear factor kappaB activation","volume":"106","author":"Shen","year":"2010","journal-title":"Circ. Res."},{"issue":"5","key":"10.1016\/j.jprot.2020.103757_bb0505","doi-asserted-by":"crossref","first-page":"267","DOI":"10.5551\/jat.10.267","article-title":"Atherosclerosis and extracellular matrix","volume":"10","author":"Katsuda","year":"2003","journal-title":"J. Atheroscler. Thromb."},{"issue":"4","key":"10.1016\/j.jprot.2020.103757_bb0510","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/joim.12486","article-title":"Vascular proteomics in metabolic and cardiovascular diseases","volume":"280","author":"Lynch","year":"2016","journal-title":"J. Intern. Med."},{"issue":"9","key":"10.1016\/j.jprot.2020.103757_bb0515","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1074\/mcp.M110.001693","article-title":"Proteomics characterization of extracellular space components in the human aorta","volume":"9","author":"Didangelos","year":"2010","journal-title":"Mol. Cell. Proteomics"},{"issue":"1","key":"10.1016\/j.jprot.2020.103757_bb0520","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1177\/1358863X08094801","article-title":"Collagens in the progression and complications of atherosclerosis","volume":"14","author":"Adiguzel","year":"2009","journal-title":"Vasc. Med."},{"issue":"2","key":"10.1016\/j.jprot.2020.103757_bb0525","doi-asserted-by":"crossref","first-page":"111","DOI":"10.5551\/jat.RV17016","article-title":"Cysteine protease cathepsins in atherosclerotic cardiovascular diseases","volume":"25","author":"Wu","year":"2018","journal-title":"J. Atheroscler. Thromb."},{"issue":"6","key":"10.1016\/j.jprot.2020.103757_bb0530","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1038\/s41569-018-0002-3","article-title":"Cysteine protease cathepsins in cardiovascular disease: from basic research to clinical trials","volume":"15","author":"Liu","year":"2018","journal-title":"Nat. Rev. Cardiol."},{"issue":"1","key":"10.1016\/j.jprot.2020.103757_bb0535","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0016185","article-title":"Biomarkers of extracellular matrix metabolism (MMP-9 and TIMP-1) and risk of stroke, myocardial infarction, and cause-specific mortality: cohort study","volume":"6","author":"Hansson","year":"2011","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.jprot.2020.103757_bb0540","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1161\/01.STR.0000196986.50059.e0","volume":"37","author":"Sluijter","year":"2006","journal-title":"Stroke"},{"issue":"2","key":"10.1016\/j.jprot.2020.103757_bb0545","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S0021-9150(03)00251-X","article-title":"Different expression of MMPs\/TIMP-1 in human atherosclerotic lesions. Relation to plaque features and vascular bed","volume":"170","author":"Orbe","year":"2003","journal-title":"Atherosclerosis"},{"issue":"17","key":"10.1016\/j.jprot.2020.103757_bb0550","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1161\/CIRCULATIONAHA.105.593483","article-title":"Elevated matrix metalloproteinase-9 associated with stroke or cardiovascular death in patients with carotid stenosis","volume":"114","author":"Eldrup","year":"2006","journal-title":"Circulation"},{"issue":"12","key":"10.1016\/j.jprot.2020.103757_bb0555","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1161\/01.CIR.0000058700.41738.12","article-title":"Plasma concentrations and genetic variation of matrix metalloproteinase 9 and prognosis of patients with cardiovascular disease","volume":"107","author":"Blankenberg","year":"2003","journal-title":"Circulation"},{"issue":"25","key":"10.1016\/j.jprot.2020.103757_bb0560","doi-asserted-by":"crossref","first-page":"2819","DOI":"10.1016\/j.jacc.2016.10.031","article-title":"Proteomics research in cardiovascular medicine and biomarker discovery","volume":"68","author":"Lam","year":"2016","journal-title":"J. Am. Coll. Cardiol."}],"container-title":["Journal of Proteomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1874391920301251?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1874391920301251?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T07:01:43Z","timestamp":1778828503000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1874391920301251"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":112,"alternative-id":["S1874391920301251"],"URL":"https:\/\/doi.org\/10.1016\/j.jprot.2020.103757","relation":{},"ISSN":["1874-3919"],"issn-type":[{"value":"1874-3919","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Molecular signatures of atherosclerotic plaques: An up-dated panel of protein related markers","name":"articletitle","label":"Article Title"},{"value":"Journal of Proteomics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jprot.2020.103757","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2020 Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"103757"}}